Login / Signup

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).

Howard H FeldmanJosé A LuchsingerGabriel C LégerCurtis TaylorDiane M JacobsDavid P SalmonSteven D EdlandKaren MesserCarolyn RevtaSarah A FlowersKerry S JonesAlbert KoulmanKevin E YarasheskiPhilip B VergheseVenky VenkateshHenrik ZetterbergJanuary DurantJody-Lynn LupoGary E Gibsonnull null
Published in: PloS one (2024)
ClinicalTrials.gov identifier: NCT06223360, registered on January 25, 2024. https://classic.clinicaltrials.gov/ct2/show/NCT06223360.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • image quality
  • randomized controlled trial
  • computed tomography
  • study protocol
  • cognitive decline
  • dual energy
  • mild cognitive impairment